Methods of reducing blood glucose or triglyceride levels by administration of METRNL protein
US10342852B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 10, 2017 |
| Grant date | Jul 9, 2019 |
| Priority date | — |
| Expiry date | Jan 28, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an application of Metrnl protein in preparing a hypolipidemic, hypoglycemic medicine or dietary supplement. The present invention further provides a method for preparing a mouse with fat-specific overexpression of Metrnl.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.